Credit Suisse Group AG (NYSE: CS)


A class action has been commenced on behalf of purchasers of Credit Suisse Group AG (NYSE: CS) common stock between March 20, 2015 to February 3, 2016 (the “Class Period”) in the U.S. District Court for the Southern District of New York.

The complaint alleges that throughout the Class Period, defendants made false and misleading statements and/or failed to disclose material adverse facts about the Company's business, operations and risk controls. Specifically, contrary to defendants’ repeated assurances that Credit Suisse maintained “comprehensive risk management processes and sophisticated control systems” in its investment operations, Credit Suisse's risk protocols and control systems were routinely disregarded, which allowed the Company to accumulate billions of dollars of risky, highly illiquid securities in violation of those risk protocols. Indeed, defendants’ scheme enabled the Company to surreptitiously accumulate $3 billion in distressed debt and U.S. collateralized loan obligations (“CLOs”), which were notoriously difficult to liquidate and required significant capital investments. This outsized, undisclosed investment violated Credit Suisse’s risk protocols and rendered it highly susceptible to losses when credit markets contracted. As a result of defendants’ false statements and/or omissions, Credit Suisse American Depositary Receipts (“ADRs”) traded at artificially inflated prices during the Class Period, reaching a high of close to $30 per share.

Then, by the beginning of 2016, with credit markets tightening, Credit Suisse could no longer hide the truth. On February 4, 2016, Credit Suisse announced its fourth quarter and fiscal year 2015 financial results, including a massive $633 million write-down from the sale of the Company’s outsized, illiquid and distressed debt and CLO positions, which would increase to nearly $1 billion in the following weeks. The Company’s recently appointed CEO, Tidjane Thiam, admitted that these risky investments were only allowed because the trading limits were continuously raised, enabling traders to take larger and larger positions in violation of Credit Suisse’s risk policies. In addition, Thiam acknowledged that the investment bank had acquired these securities over the years because it was “trying to generate revenue at all costs.” In reaction to this news, the price of Credit Suisse ADRs declined 11%, from a close of $16.69 per share on February 3, 2016 to a close of $14.89 per share on February 4, 2016.

If you are a current shareholder and purchased stock between March 20, 2015 to February 3, 2016, and would like to discuss your options of exercising your rights as a shareholder, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.

Personal Information
Name:
Phone #:
E-mail Address:
Stock Information
Do you currently own the stock? Yes   No
Purchase Date:
Quantity Purchased:
Purchase Price Per Share:

Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.